TBF1.F - Canntab Therapeutics Limited

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Annual

Cash Flow

All numbers in thousands
Breakdown
ttm
2018-05-31
2017-12-31
2017-05-31
2016-12-31
2015-12-31
Cash flows from operating activities
Net Income
-3,571
-2,408
-182
-1,116
520
-174
Depreciation & amortization
83
51
-
2
-
-
Deferred income taxes
-
-
-
-
-
-
Stock based compensation
596
320
0
682
51
-
Change in working capital
11
108
73
78
-128
-84
Accounts receivable
-196
-129
0
20
-8
-43
Inventory
-
-
-
-
-
-
Accounts Payable
-
-
-
-
-
-
Other working capital
-2,558
-1,468
-115
-454
-409
-258
Other non-cash items
-
660
-
-
51
-
Net cash provided by operating activites
-2,275
-1,269
-115
-355
-409
-258
Cash flows from investing activities
Investments in property, plant and equipment
-283
-199
-
-100
-
-
Acquisitions, net
-
-
-
-
-
-
Purchases of investments
-
-
-
-
-
-
Sales/Maturities of investments
-
-
-
-
-
-
Other investing activites
-
-
-
-
0
-
Net cash used for investing activites
-283
-199
0
-100
1,166
-
Cash flows from financing activities
Debt repayment
-
-
-
-
-
-
Common stock issued
-
5,008
100
1,413
-
150
Common stock repurchased
-
-
-
-
-
-
Dividends Paid
-
-
-
-
-
-
Other financing activites
-
-481
-
-
-852
201
Net cash used privided by (used for) financing activities
4,749
4,727
100
1,413
-852
351
Net change in cash
-
-
-15
959
-95
93
Cash at beginning of period
237
959
16
0
111
17
Cash at end of period
2,428
4,218
1
959
16
111
Free Cash Flow
Operating Cash Flow
-2,275
-1,269
-115
-355
-409
-258
Capital Expenditures
-283
-199
-
-100
-
-
Free Cash Flow
-2,558
-1,468
-115
-454
-409
-258